<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: The purpose of present study was to investigate the methylation status of the promoter region in five genes (mothers against decapentaplegic homolog 4, fragile histidine triad protein, <z:hpo ids='HP_0011420'>death</z:hpo>-associated protein kinase 1, <z:mpath ids='MPATH_271'>adenomatous polyposis coli</z:mpath> (APC), and E-cadherin), which are known to be involved in the pathogenesis of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) and its clinicopathological significance </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The study subjects were 60 CRC patients, 40 patients with adenomatous colorectal <z:mpath ids='MPATH_491'>polyp</z:mpath> and 60 healthy control individuals </plain></SENT>
<SENT sid="2" pm="."><plain>We further enrolled a total of 16 patients (two patients with <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo>, two patients with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo>, one patient with serrated <z:mpath ids='MPATH_270'>adenoma</z:mpath>, and 11 patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>The methylation states of the five genes were determined in peripheral blood plasma using methylation-specific polymerase chain reaction single-strand conformation polymorphism analysis </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: This study showed the most sensitive epigenetic markers, E-cadherin (60 %), followed by APC (57 %), for detecting <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>E-cadherin and APC had similar specificities and amplified 84 and 86 %, respectively, of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients compared to non-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
<SENT sid="6" pm="."><plain>Additionally, APC was the only marker to be significantly increased (OR = 6.67, 95 % CI = 1.19-23.4, P = 0.045) and the most sensitive (57 %) and specific (89 %) marker in stage I <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Though we have not examined the paired <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissues and plasma, there was relatively high concordant rate (60-80 %) in our limited number of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Five genes, promoter methylation, in plasma were statistically significant risk factors in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
<SENT sid="9" pm="."><plain>In this study, E-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">cad</z:e> and APC genes may be particularly useful epigenetic biomarkers in plasma for the detection of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Additionally, APC may able to identify early potential <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>